Functional genomics and AI approaches
The company uses these approaches to identify novel cancer immunology drug targets.
Source: LinkedIn company description · Retrieved October 13, 2026
GV20 Therapeutics is a therapeutics company with sites in Cambridge, USA, and Shanghai, China.
The company uses high-throughput functional genomics and AI to identify cancer immunology drug targets and discover and develop antibody drugs for cancer. GV20 has an immuno-oncology antibody drug candidate portfolio for cancer treatment.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company uses these approaches to identify novel cancer immunology drug targets.
Source: LinkedIn company description · Retrieved October 13, 2026
The company discovers and develops antibody drugs for cancer.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 10, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 23, 2026, September 26, 2026, September 27, 2026, September 28, 2026, September 30, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.